SPGRX
Price
$18.95
Change
+$0.19 (+1.01%)
Updated
Jun 6 closing price
Net Assets
85.05M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

SPGRX vs VITSX

Header iconSPGRX vs VITSX Comparison
Open Charts SPGRX vs VITSXBanner chart's image
DWS Equity Sector Strategy Fund
Price$18.95
Change+$0.19 (+1.01%)
VolumeN/A
Net Assets85.05M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
SPGRX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SPGRX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPGRX is a StrongBuy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. SPGRX (85M). VITSX pays higher dividends than SPGRX: VITSX (1.29) vs SPGRX (1.18). SPGRX was incepted earlier than VITSX: SPGRX (29 years) vs VITSX (28 years). SPGRX (0.81) is less costly to investors than VITSX (0.03). SPGRX is a more actively managed with annual turnover of: 28.00 vs. VITSX (2.00). SPGRX has a lower initial minimum investment than VITSX: SPGRX (2500) vs VITSX (5000000). SPGRX (11.51) and VITSX (10.97) have marching annual gain over last year. VITSX return over 5 years is better than : 80.96 vs. SPGRX (33.30).
SPGRXVITSXSPGRX / VITSX
Total Expense Ratio0.480.031,600%
Annual Report Gross Expense Ratio0.810.032,700%
Fund Existence29 years28 years-
Gain YTD3.0770.833369%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets85M1.82T0%
Annual Yield % from dividends1.181.2992%
Returns for 1 year11.5110.97105%
Returns for 3 years43.9540.35109%
Returns for 5 years33.3080.9641%
Returns for 10 years50.43180.4928%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.